EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study

Britt W H van der Arend iD, Mirthe M Bloemhof, Alle G van der Schoor, Erik W van Zwet, Gisela M Terwindt

Cephalalgia · 2023-09 · 43 (9)

DOI: 10.1177/03331024231198792 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cephalalgia, online erschienen am 08.09.2023. Verfasst von Britt W H van der Arend und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Migraine Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This longitudinal cohort study aimed to investigate changes in migraine-related outcomes following COVID-19 infection and vaccination.

Methods

We identified 547 clinically diagnosed migraine patients from the Leiden Headache Center who kept a headache E-diary during the COVID-19 pandemic (February 2020 to August 2022). We sent a questionnaire to register their COVID-19 infection and/or vaccination dates. After applying inclusion criteria, n = 59 participants could be included in the infection analysis and n = 147 could be included in the vaccination analysis. Primary outcome was the change in monthly migraine days (MMD) between 1 month prior and 1 month post COVID-19 infection or vaccination. Secondary outcome variables were change in monthly headache days (MHD) and monthly acute medication days (MAMD).

Results

Vaccination against COVID-19 was associated with an increase in MMD (1.06; 95% confidence interval [CI] = 0.57–1.55; p < 0.001), MHD (1.52; 95% CI = 0.91–2.14; p < 0.001) and MAMD (0.72; 95% CI = 0.33–1.12; p < 0.001) in the first month post-vaccination. COVID-19 infection solely increased the number of MAMD (1.11; 95% CI = 0.10–1.62; p < 0.027), but no statistically significant differences in MMD or MHD were observed.

Conclusions

Our findings imply that vaccination against COVID-19 is associated with an increase in migraine, indicating a possible role of inflammatory mediators in migraine pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Migraine DisordersHumansLongitudinal StudiesPandemicsCohort StudiesHeadacheVaccination

Stichwörter der Autor:innen

COVID-19SARS-CoV-2headacheinfectionmigrainevaccination

Autor:innen und Institutionen

  • Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Internal Medicine, Erasmus University, Rotterdam, The Netherlands.
  • Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Britt W H van der Arend

Zitieren

APA

van der Arend, B. W. H., Bloemhof, M. M., van der Schoor, A. G., van Zwet, E. W., & Terwindt, G. M. (2023). Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study. Cephalalgia, 43(9). https://doi.org/10.1177/03331024231198792

Vancouver

van der Arend BWH, Bloemhof MM, van der Schoor AG, van Zwet EW, Terwindt GM. Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study. Cephalalgia. 2023;43(9). doi:10.1177/03331024231198792

BibTeX
@article{vanderArend2023,
  author = {van der Arend, Britt W H and Bloemhof, Mirthe M and van der Schoor, Alle G and van Zwet, Erik W and Terwindt, Gisela M},
  title = {Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study},
  journal = {Cephalalgia},
  year = {2023},
  volume = {43},
  number = {9},
  doi = {10.1177/03331024231198792}
}
Kostenlos starten →